Derek Marsee, Ph.D.
Affiliations: | 2004 | Ohio State University, Columbus, Columbus, OH |
Area:
Molecular Biology, Cell Biology, GeneticsGoogle:
"Derek Marsee"Mean distance: 6635.5
Parents
Sign in to add mentor| Sissy M. Jhiang | grad student | 2004 | Ohio State | |
| (Exploration of novel therapies for thyroid cancer: Adenoviral gene therapy and 17-allylamino-17-demethoxygeldanamycin.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Marsee DK, Vadysirisack DD, Morrison CD, et al. (2005) Variable expression of coxsackie-adenovirus receptor in thyroid tumors: implications for adenoviral gene therapy. Thyroid : Official Journal of the American Thyroid Association. 15: 977-87 |
| Venkateswaran A, Marsee DK, Green SH, et al. (2004) Forskolin, 8-Br-3',5'-cyclic adenosine 5'-monophosphate, and catalytic protein kinase A expression in the nucleus increase radioiodide uptake and sodium/iodide symporter protein levels in RET/PTC1-expressing cells. The Journal of Clinical Endocrinology and Metabolism. 89: 6168-72 |
| Marsee DK, Venkateswaran A, Tao H, et al. (2004) Inhibition of heat shock protein 90, a novel RET/PTC1-associated protein, increases radioiodide accumulation in thyroid cells. The Journal of Biological Chemistry. 279: 43990-7 |
| Marsee DK, Shen DH, MacDonald LR, et al. (2004) Imaging of metastatic pulmonary tumors following NIS gene transfer using single photon emission computed tomography. Cancer Gene Therapy. 11: 121-7 |
| Shen DH, Marsee DK, Schaap J, et al. (2004) Effects of dose, intervention time, and radionuclide on sodium iodide symporter (NIS)-targeted radionuclide therapy. Gene Therapy. 11: 161-9 |